TABLE 1.
Relationship between serum CHI3L1 level and clinicopathological characteristics in the HCC group
| All patients (n = 128) | CHI3L1 (ng/ml) | ||
|---|---|---|---|
| Variable | n | Median (P25, P75) | p‐value |
| Gender | |||
| Male | 104 | 168.76 (94.23, 329.01) | 0.7725 |
| Female | 24 | 174.65 (104.91, 290.19) | |
| Age (years) | |||
| ≤60 | 64 | 137.24 (83.97, 408.92) | 0.1635 |
| >60 | 64 | 201.08 (116.9, 310.88) | |
| AFP (ng/ml) | |||
| ≤400 | 68 | 129.16 (81.03, 232.42) | <0.0001 |
| >400 | 50 | 241.95 (143.61, 459.37) | |
| Cirrhosis | |||
| No | 36 | 109.97 (62.02, 164.29) | <0.0001 |
| Yes | 86 | 224.17 (108.37, 449.64) | |
| Child‐pugh grade | |||
| A | 53 | 146.46 (94.50, 270.66) | <0.0001 |
| B + C | 33 | 432.63 (239.79, 682.53) | |
| Size of tumor (cm) | |||
| ≤5 | 67 | 118.42 (80.80, 231.61) | 0.0379 |
| >5 | 40 | 156.50 (106.11, 438.35) | |
| TNM stage | |||
| Ⅰ + Ⅱ | 48 | 104.02 (78.07, 161.44) | <0.0001 |
| Ⅲ + Ⅳ | 75 | 242.46 (143.23, 459.25) | |